MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.120
-0.070 (-5.88%)
At close: Oct 30, 2026, 4:00 PM EDT
1.180
+0.060 (5.36%)
After-hours: Oct 30, 2026, 7:30 PM EDT
MetaVia Employees
MetaVia had 8 employees as of December 31, 2025. The number of employees decreased by 1 or 11.11% compared to the previous year. That makes MetaVia the 40,832nd largest employer in the world and 6,174th in the United States.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,805,750
Market Cap
7.38M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | -1 | -11.11% |
| Dec 31, 2024 | 9 | 1 | 12.50% |
| Dec 31, 2023 | 8 | 6 | 300.00% |
| Dec 31, 2022 | 2 | -3 | -60.00% |
| Dec 31, 2021 | 5 | -2 | -28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| CollPlant Biotechnologies | 39 |
| Moleculin Biotech | 17 |
| Theriva Biologics | 16 |
| Soligenix | 14 |
| Ensysce Biosciences | 10 |
| CNS Pharmaceuticals | 8 |
| Lexaria Bioscience | 7 |
MTVA News
- 3 days ago - MetaVia to Present Phase 1 Clinical Trial Data for DA-1726 in Oral Presentation at the Precision Liver Symposium 2026 - PRNewsWire
- 18 days ago - MetaVia names Sarah Browne, M.D., as Chief Medical Officer - TheFly
- 18 days ago - MetaVia Appoints Seasoned Clinical Development Executive Sarah Browne, M.D., as Chief Medical Officer - PRNewsWire
- 7 weeks ago - MetaVia reports results from DA-1726-derived radioactivity study - TheFly
- 7 weeks ago - MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction - PRNewsWire
- 2 months ago - MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 2 months ago - MetaVia Earnings release: Q2 2026 - Filings
- 2 months ago - MetaVia Quarterly report: Q2 2026 - Filings